• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.05% Nasdaq Down 1.17%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    87.41 Down 1.59(1.79%) 11:14AM EDT - Nasdaq Real Time Price
    Prev Close:89.00
    Open:88.50
    Bid:87.21 x 700
    Ask:87.24 x 500
    1y Target Est:111.48
    Beta:1.25203
    Earnings Date:Jul 26 - Aug 1 (Est.)
    Day's Range:87.00 - 89.11
    52wk Range:81.89 - 123.37
    Volume:3,660,908
    Avg Vol (3m):12,109,600
    Market Cap:118.41B
    P/E (ttm):7.34
    EPS (ttm):11.91
    Div & Yield:1.72 (1.95%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 1.79%118.41B
    GSKDown 0.23%104.52B
    PFEUp 3.48%210.15B

    Key Statistics

    Forward P/E (1 yr):7.03
    P/S (ttm):3.73
    Ex-Dividend Date:14-Mar-16

    Analysts

    Annual EPS Est (Dec-16) :12.13
    Quarterly EPS Est (Jun-16) :3.00
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):5.87

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback